NC
ONCS

Nexthera Capital’s OncoSec Medical Incorporated ONCS Stock Holding History

Nexthera Capital’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,313
Closed -$1.94M – 56
2018
Q3 		$1.94M Sell
6,313
-5,570
-47% -$1.71M 0.37% 38
2018
Q2 		$3.61M Buy
11,883
+2,500
+27% +$876K 0.56% 33
2018
Q1 		$3.88M Buy
+9,383
New +$3.85M 0.64% 33

Other funds holding ONCS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Nexthera Capital's ONCS Position: Q4 2018 in Review

Nexthera Capital sold out of OncoSec Medical Incorporated (ONCS) in Q4 2018, closing a stake of 6,313 shares — an estimated $1.94M sold.

Nexthera Capital first reported a position in ONCS in Q1 2018 and held it in 3 quarters. The position peaked at $3.88M in Q1 2018. 33 funds tracked by Wall St. Rank hold ONCS as of Q4 2018.

  • Nexthera Capital reported no remaining OncoSec Medical Incorporated position as of Q4 2018 after selling out during the quarter.
  • Nexthera Capital sold 6,313 OncoSec Medical Incorporated shares in Q4 2018, an estimated $1.94M.
  • Nexthera Capital first reported a position in OncoSec Medical Incorporated in Q1 2018 and held it in 3 quarters.
  • Nexthera Capital's OncoSec Medical Incorporated position peaked at $3.88M in Q1 2018.
  • 33 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.